Showing results (11-20 of 163) with videos related to
Sort By:
Pageof 17
Expert Review of Clinical Immunology|February 4, 2021
The interleukin-1 family cytokines in psoriasis: pathogenetic role and therapeutic perspectivesHelena Iznardo, Lluís PuigInternational Journal of Molecular Sciences|January 23, 2024
Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and PsoriasisLluís Rusiñol, Lluís PuigCurrent Opinion in Rheumatology|June 14, 2022
Beyond plaque psoriasis - pathogenesis and treatment of other psoriasis phenotypesHelena Iznardo, Lluís PuigExpert Opinion on Drug Safety|February 14, 2020
The safety of brodalumab for the treatment of psoriasisHelena Iznardo, Lluís PuigExpert Review of Clinical Immunology|December 4, 2020
Therapeutic targeting of the IL-13 pathway in skin inflammationCarla Tubau, Lluís PuigInternational Journal of Molecular Sciences|April 30, 2021
Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic DiseaseHelena Iznardo, Lluís PuigActa Dermato-Venereologica|July 7, 2017
The AGEs of Psoriasis: A Biomarker for Severity and a Pathogenetic Link to ComorbiditiesLluís Puig, Anna López-FerrerImmunotherapy|April 22, 2020
Guselkumab in the treatment of moderate-to-severe plaque psoriasisCristina López-Sánchez, Lluís PuigExpert Opinion on Drug Safety|April 4, 2020
Safety of calcipotriene and betamethasone dipropionate foam for the treatment of psoriasisVictoria Amat-Samaranch, Lluís PuigDermatology (Basel, Switzerland)|January 10, 2015
Long-term efficacy, safety and drug survival of ustekinumab in a Spanish cohort of patients with moderate to severe plaque psoriasisLluís Puig, Veronica Ruiz-SalasPageof 17